| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Hyep Ivan is a Chief Financial Officer at Bicara Therapeutics Inc.. Recent SEC Form 4 filings include 0 buys and 7 sells.
Estimated insider holdings value: $3.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 22, 2025 | BCAX Bicara Therapeutics Inc. | Chief Financial Officer | Sale+OE | 9,200 | $18.31 | $168,491.56 | -6.0% | +0.4% | - | |
| Nov 24, 2025 | BCAX Bicara Therapeutics Inc. | Chief Financial Officer | Sale+OE | 18,400 | $18.54 | $341,074.44 | -6.0% | -13.1% | - | |
| Oct 9, 2025 | BCAX Bicara Therapeutics Inc. | Chief Financial Officer | Sale+OE | 6,415 | $18.23 | $116,931.34 | -4.2% | -6.0% | - | |
| Oct 8, 2025 | BCAX Bicara Therapeutics Inc. | Chief Financial Officer | Sale+OE | 30,385 | $18.21 | $553,198.15 | -6.5% | -10.1% | - |